Advanced therapies have ground-breaking therapeutic potential, particularly in disease areas where there is an unmet medical need and available therapeutic options are absent or inadequate. These […]
2021 is set to be another landmark year in the area of health. It is hoped to not only relieve the burden of the COVID-19 pandemic […]
The Global Access to Innovations in Healthtech Summit is a biennial EXCITE International summit, a Canada based not-for-profit initiative. The 2021 edition will be organized in […]
Join the EuropaBio Healthcare Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the ongoing […]
Building on the experience of the EU Task Force for Industrial Scale-up of COVID-19 vaccines, the European Commission will facilitate cooperation between actors in the supply […]
The EU Pharmaceutical Strategy is looking to improve patients’ access to therapies for challenging and rare conditions. The EU legislation on cross-border healthcare is an important […]
Germany's largest biotech event, the German Biotechnology Days 2021 (Deutsche Biotechnologietage, DBT), will take place on 20th and 21st September in Stuttgart. With over 800 participants, […]
The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech […]
The European Health and Digital Executive Agency (HaDEA) with the support of the European Commission organizes an info session to present three HERA’s public procurement calls […]
Join the inaugural Rare Conversations Conference aimed at facilitating essential discussion on the future of the rare disease and OMP ecosystem involving leading experts.The event will […]
The existence of messenger(m) RNA was hypothesized early in the days of DNA breakthroughs in the 1960s, and research from the 1990s started to reveal its potential as a therapeutic tool.
The Innovative Health Initiative (IHI) aims to build on the successes of the Innovative Medicines ...
